These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 17582210

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. DNA vaccination against Japanese cedar pollinosis in dogs suppresses type I hypersensitivity by controlling lesional mast cells.
    Masuda K.
    Vet Immunol Immunopathol; 2005 Oct 18; 108(1-2):185-7. PubMed ID: 16098609
    [Abstract] [Full Text] [Related]

  • 3. Recombinant Fusion Allergens, Cry j 1 and Cry j 2 from Japanese Cedar Pollen, Conjugated with Polyethylene Glycol Potentiate the Attenuation of Cry j 1-Specific IgE Production in Cry j 1-Sensitized Mice and Japanese Cedar Pollen Allergen-Sensitized Monkeys.
    Fujimura T, Fujinami K, Ishikawa R, Tateno M, Tahara Y, Okumura Y, Ohta H, Miyazaki H, Taniguchi M.
    Int Arch Allergy Immunol; 2015 Oct 18; 168(1):32-43. PubMed ID: 26524293
    [Abstract] [Full Text] [Related]

  • 4. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
    Sone T, Dairiki K, Morikubo K, Shimizu K, Tsunoo H, Mori T, Kino K.
    Clin Exp Allergy; 2005 May 18; 35(5):664-71. PubMed ID: 15898991
    [Abstract] [Full Text] [Related]

  • 5. Identification of Cha o 3 homolog Cry j 4 from Cryptomeria japonica (Japanese cedar) pollen: Limitation of the present Japanese cedar-specific ASIT.
    Osada T, Tanaka Y, Yamada A, Sasaki E, Utsugi T.
    Allergol Int; 2018 Oct 18; 67(4):467-474. PubMed ID: 29525489
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of an Allergen-Antibody Reaction Related to Japanese Cedar Pollinosis Using DNA Aptamers Against the Cry j 2 Allergen.
    Ogihara K, Savory N, Abe K, Yoshida W, Arakawa M, Asahi M, Kamohara S, Ikebukuro K.
    Nucleic Acid Ther; 2015 Dec 18; 25(6):311-6. PubMed ID: 26484654
    [Abstract] [Full Text] [Related]

  • 7. Cross-reactivity between major IgE core epitopes on Cry j 2 allergen of Japanese cedar pollen and relevant sequences on Cha o 2 allergen of Japanese cypress pollen.
    Miyaji K, Okamoto N, Saito A, Yasueda H, Takase Y, Shimakura H, Saito S, Sakaguchi M.
    Allergol Int; 2016 Jul 18; 65(3):286-92. PubMed ID: 26916996
    [Abstract] [Full Text] [Related]

  • 8. Oral immunotherapy with transgenic rice seed containing destructed Japanese cedar pollen allergens, Cry j 1 and Cry j 2, against Japanese cedar pollinosis.
    Wakasa Y, Takagi H, Hirose S, Yang L, Saeki M, Nishimura T, Kaminuma O, Hiroi T, Takaiwa F.
    Plant Biotechnol J; 2013 Jan 18; 11(1):66-76. PubMed ID: 23066780
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association between first airborne cedar pollen level peak and pollinosis symptom onset: a web-based survey.
    Bando H, Sugiura H, Ohkusa Y, Akahane M, Sano T, Jojima N, Okabe N, Imamura T.
    Int J Environ Health Res; 2015 Jan 18; 25(1):104-13. PubMed ID: 24720339
    [Abstract] [Full Text] [Related]

  • 11. Safety and efficacy of a new regimen of short-term oral immunotherapy with Cry j 1-galactomannan conjugate for Japanese cedar pollinosis: a prospective, randomized, open-label study.
    Murakami D, Sawatsubashi M, Kikkawa S, Ejima M, Saito A, Kato A, Komune S.
    Allergol Int; 2015 Apr 18; 64(2):161-8. PubMed ID: 25838092
    [Abstract] [Full Text] [Related]

  • 12. A correlation between symptom severity and unbalanced reactive IgA production in Japanese cedar pollinosis patients.
    Komatsu N, Harada M, Nakagawa M, Tanaka Y, Ono T, Gohara S, Ohkubo K, Itoh K.
    Asian Pac J Allergy Immunol; 2008 Apr 18; 26(2-3):97-104. PubMed ID: 19054927
    [Abstract] [Full Text] [Related]

  • 13. T cell epitopes in Japanese cedar (Cryptomeria japonica) pollen allergens: choice of major T cell epitopes in Cry j 1 and Cry j 2 toward design of the peptide-based immunotherapeutics for the management of Japanese cedar pollinosis.
    Sone T, Morikubo K, Miyahara M, Komiyama N, Shimizu K, Tsunoo H, Kino K.
    J Immunol; 1998 Jul 01; 161(1):448-57. PubMed ID: 9647255
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analysis of helper T cell responses to Cry j 1-derived peptides in patients with nasal allergy: candidate for peptide-based immunotherapy of Japanese cedar pollinosis.
    Masuyama K, Chikamatsu K, Ikagawa S, Matsuoka T, Takahashi G, Yamamoto T, Endo S.
    Allergol Int; 2009 Mar 01; 58(1):63-70. PubMed ID: 19050376
    [Abstract] [Full Text] [Related]

  • 16. Immunological parameters associated with the development of allergic rhinitis: a preliminary prospective study.
    Uekusa Y, Inamine A, Yonekura S, Horiguchi S, Fujimura T, Sakurai D, Yamamoto H, Suzuki H, Hanazawa T, Okamoto Y.
    Am J Rhinol Allergy; 2012 Mar 01; 26(2):92-6. PubMed ID: 22487284
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Immunological and Symptomatic Effects of Oral Intake of Transgenic Rice Containing 7 Linked Major T-Cell Epitopes from Japanese Cedar Pollen Allergens.
    Endo T, Asaka D, Nakayama T, Saito S, Kodama H, Mitsuyoshi R, Takaishi S, Sugimoto N, Omae S, Takagi H, Wakasa Y, Ozawa K, Takano M, Takaiwa F, Kojima H, Saito S.
    Int Arch Allergy Immunol; 2021 Mar 01; 182(2):109-119. PubMed ID: 32854094
    [Abstract] [Full Text] [Related]

  • 19. Effect of antihistamine eye drops on the conjunctival provocation test with Japanese cedar pollen allergen.
    Dake Y, Enomoto T, Cheng L, Enomoto K, Shibano A, Ikeda H, Yoda S, Yajin S, Sakota T, Yamanishi E.
    Allergol Int; 2006 Dec 01; 55(4):373-8. PubMed ID: 17130679
    [Abstract] [Full Text] [Related]

  • 20. [A study of aggravation of atopic dermatitis during Japanese cedar pollen season--correlation with grades of dermatitis on face and Cry j 1 specific IgE].
    Aihara M, Takahashi S, Oosuna I, Yasueda H, Tsubaki K, Ikezawa Z.
    Arerugi; 1999 Oct 01; 48(10):1172-9. PubMed ID: 10554404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.